Bangzhong Z. Lin

Osaka, 5650871, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Structure-Activity-Property Relationships of MZ1-Based Trivalent PROTACs Incorporating a 1,2,5-Trisubstituted Benzene Linker.

Structure-Activity-Property Relationships of MZ1-Based Trivalent PROTACs Incorporating a 1,2,5-Trisubstituted Benzene Linker.

Journal: Chemical & pharmaceutical bulletin
Published: July 30, 2026

An Improved Brain-Penetrating Nanoformulation of the VIPR2 Antagonist Peptide KS-133 for Treating Cognitive Impairment in Schizophrenia.

An Improved Brain-Penetrating Nanoformulation of the VIPR2 Antagonist Peptide KS-133 for Treating Cognitive Impairment in Schizophrenia.

Journal: Biological & pharmaceutical bulletin
Published: June 28, 2026

Polycyclic quinone compounds containing a six-membered silacycle suppress ferroptosis in vitro.

Polycyclic quinone compounds containing a six-membered silacycle suppress ferroptosis in vitro.

Journal: Free radical research
Published: May 29, 2026

Combination therapy with clinically approved PPARα/δ/γ subtype-selective agonists pemafibrate, seladelpar, and pioglitazone in a 4-week diet-induced early-stage MASLD mouse model.

Combination therapy with clinically approved PPARα/δ/γ subtype-selective agonists pemafibrate, seladelpar, and pioglitazone in a 4-week diet-induced early-stage MASLD mouse model.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 06, 2026

An Orally Available Derivative of a Specific CK2 Inhibitor for Regulating Circadian Rhythms and Acute Myeloid Leukemia.

An Orally Available Derivative of a Specific CK2 Inhibitor for Regulating Circadian Rhythms and Acute Myeloid Leukemia.

Journal: Precision chemistry
Published: November 09, 2025

Novel Ligands for the Orphan Receptor GPR151 Modulate Morphine Action.

Novel Ligands for the Orphan Receptor GPR151 Modulate Morphine Action.

Journal: Genes to cells : devoted to molecular & cellular mechanisms
Published: August 25, 2025

Compound Library Screening Identified Cladribine as a Novel Radiosensitizer for Prostate Cancer.

Compound Library Screening Identified Cladribine as a Novel Radiosensitizer for Prostate Cancer.

Journal: Cancer science
Published: August 13, 2025

Claudin 5-binding small molecule transiently opens the blood-brain barrier and safely enhances brain drug delivery.

Claudin 5-binding small molecule transiently opens the blood-brain barrier and safely enhances brain drug delivery.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: July 22, 2025

Correction: Anti-schistosomal activity and ADMET properties of 1,2,5-oxadiazinane-containing compound synthesized by visible-light photoredox catalysis.

Correction: Anti-schistosomal activity and ADMET properties of 1,2,5-oxadiazinane-containing compound synthesized by visible-light photoredox catalysis.

Journal: RSC medicinal chemistry
Published: October 14, 2024

Anti-Schistosomal activity and ADMET properties of 1,2,5-oxadiazinane-containing compound synthesized by visible-light photoredox catalysis.

Anti-Schistosomal activity and ADMET properties of 1,2,5-oxadiazinane-containing compound synthesized by visible-light photoredox catalysis.

Journal: RSC medicinal chemistry
Published: August 03, 2024

Modulation of Ca2+ oscillation following ischemia and nicotinic acetylcholine receptors in primary cortical neurons by high-throughput analysis.

Modulation of Ca2+ oscillation following ischemia and nicotinic acetylcholine receptors in primary cortical neurons by high-throughput analysis.

Journal: Scientific reports
Published: July 27, 2024

Development of a high-throughput screening system targeting the protein-protein interactions between PRL and CNNM.

Development of a high-throughput screening system targeting the protein-protein interactions between PRL and CNNM.

Journal: Scientific reports
Published: July 20, 2024
Showing 1-12 of 31

Last Updated: 09/26/2026